SUN2: A potential therapeutic target in cancer

The incidence of cancer is increasing at an alarming rate despite recent advances in prevention strategies, diagnostics and therapeutics for various types of cancer. The identification of novel biomarkers to aid in prognosis and treatment for cancer is urgently required. Uncontrolled proliferation and dysregulated apoptosis are characteristics exhibited by cancer cells in the initiation of various types of cancer. Notably, aberrant expression of crucial oncogenes or cancer suppressors is a defining event in cancer occurrence. Research has demonstrated that SAD1/UNC84 domain protein-2 (SUN2) serves a suppressive role in breast cancer, atypical teratoid/rhabdoid tumors and lung cancer progression. Furthermore, SUN2 inhibits cancer cell proliferation, migration and promotes apoptosis. Recent reports have also shown that SUN2 serves prominent roles in resistance to the excessive DNA damage that destabilizes the genome and promotes cancer development, and these functions of SUN2 are critical for evading initiation of cancer. Additionally, increasing evidence has demonstrated that SUN2 is involved in maintaining cell nuclear structure and appears to be a central component for organizing the natural nuclear architecture in cancer cells. The focus of the present review is to provide an overview on the pharmacological functions of SUN2 in cancers. These findings suggest that SUN2 may serve as a promising therapeutic target and novel predictive marker in various types of cancer.

[1]  Wei-Guo Zhu,et al.  Ubiquitin-like modifications in the DNA damage response. , 2017, Mutation research.

[2]  K. Linher-Melville,et al.  The complex roles of STAT3 and STAT5 in maintaining redox balance: Lessons from STAT-mediated xCT expression in cancer cells , 2017, Molecular and Cellular Endocrinology.

[3]  E. Petricoin,et al.  The Warburg Effect and Mass Spectrometry-based Proteomic Analysis. , 2017, Cancer genomics & proteomics.

[4]  A. Sica,et al.  Metabolic regulation of suppressive myeloid cells in cancer. , 2017, Cytokine & growth factor reviews.

[5]  B. Yousefi,et al.  DNA repair and damage pathways in breast cancer development and therapy. , 2017, DNA repair.

[6]  D. P. Mishra,et al.  Therapeutic Targeting of Poly(ADP‐Ribose) Polymerase‐1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities , 2017, Medicinal research reviews.

[7]  Xiao-ling He,et al.  Down-regulation of adenosine monophosphate–activated protein kinase activity: A driver of cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[8]  C. Fan,et al.  Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases , 2017, Front. Immunol..

[9]  U. Matulonis,et al.  PARP inhibitors in ovarian cancer: evidence, experience and clinical potential , 2017, Therapeutic advances in medical oncology.

[10]  X. Niu,et al.  Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth , 2016, Oncotarget.

[11]  J. Behravan,et al.  MiR 221/222 as New Players in Tamoxifen Resistance. , 2017, Current pharmaceutical design.

[12]  N. Turner,et al.  The role of mitochondrial sirtuins in health and disease. , 2016, Free radical biology & medicine.

[13]  A. Carè,et al.  Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma , 2016, Journal of Translational Medicine.

[14]  T. Sim,et al.  Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations , 2016, Cancer biology & therapy.

[15]  Y. Sang,et al.  SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer , 2015, Scientific Reports.

[16]  Shimin Zhao,et al.  NADP(+)-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance. , 2015, Molecular cell.

[17]  N. Munshi,et al.  A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells , 2015, Clinical Cancer Research.

[18]  Guoxin Li,et al.  miR-221 and miR-222 Simultaneously Target RECK and Regulate Growth and Invasion of Gastric Cancer Cells , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[19]  Eshel Ben-Jacob,et al.  The motility-proliferation-metabolism interplay during metastatic invasion , 2015, Scientific Reports.

[20]  H. Klocker,et al.  Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate , 2015, PloS one.

[21]  J. Garber,et al.  PARP inhibitors in the management of breast cancer: current data and future prospects , 2015, BMC Medicine.

[22]  Suk Woo Nam,et al.  MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer. , 2015, Journal of hepatology.

[23]  N. Matsuura,et al.  Global loss of a nuclear lamina component, lamin A/C, and LINC complex components SUN1, SUN2, and nesprin-2 in breast cancer , 2015, Cancer medicine.

[24]  A. Orekhov,et al.  Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling , 2015, BioMed research international.

[25]  Zhuo Yu,et al.  ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells , 2015, OncoTarget.

[26]  M. Horinaka,et al.  Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells , 2015, PloS one.

[27]  Juan Liu,et al.  RRAD inhibits the Warburg effect through negative regulation of the NF-κB signaling , 2015, Oncotarget.

[28]  R. Cairns.  Drivers of the Warburg phenotype. , 2015, Cancer journal.

[29]  Xiaoming Qi,et al.  MicroRNA‐320a inhibits cell proliferation, migration and invasion by targeting BMI‐1 in nasopharyngeal carcinoma , 2014, FEBS letters.

[30]  Chi-Hung Lin,et al.  Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors. , 2014, Carcinogenesis.

[31]  Xi Chen,et al.  A microRNA 221- and 222-Mediated Feedback Loop, via PDLIM2, Maintains Constitutive Activation of NFκB and STAT3 in Colorectal Cancer Cells , 2014 .

[32]  Si-hai Liu,et al.  Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer , 2014, Medical Oncology.

[33]  Feipeng Zhao,et al.  MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma , 2014, Molecular Cancer.

[34]  K. Choy,et al.  miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis , 2014, Molecular Cancer.

[35]  Min Zhang,et al.  SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer , 2014, Tumor Biology.

[36]  H. Faneca,et al.  MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer , 2014, International journal of nanomedicine.

[37]  Q. Meng,et al.  Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3 , 2014, Cancer Gene Therapy.

[38]  Zuoren Yu,et al.  miR-221/222 Promotes S-Phase Entry and Cellular Migration in Control of Basal-Like Breast Cancer , 2014, Molecules.

[39]  Jacco van Rheenen,et al.  Imaging hallmarks of cancer in living mice , 2014, Nature Reviews Cancer.

[40]  Qianchuan Zhao,et al.  MiRNA-125a-5p: a regulator and predictor of gefitinib’s effect on nasopharyngeal carcinoma , 2014, Cancer Cell International.

[41]  X Wang,et al.  Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer , 2014, Oncogene.

[42]  P. Tassone,et al.  In Vitro and In Vivo Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells , 2014, PloS one.

[43]  C. Zhang,et al.  miR-221/222 confers radioresistance in glioblastoma cells through activating Akt independent of PTEN status. , 2014, Current molecular medicine.

[44]  L. Mariani,et al.  Emerging Biological Treatments for Uterine Cervical Carcinoma , 2014, Journal of Cancer.

[45]  J. Qin,et al.  MicroRNA‐221 promotes colorectal cancer cell invasion and metastasis by targeting RECK , 2014, FEBS letters.

[46]  A. Iwasaki,et al.  Epigenetic Reprogramming of the Type III Interferon Response Potentiates Antiviral Activity and Suppresses Tumor Growth , 2014, PLoS biology.

[47]  K. Sun,et al.  Anti-miRNA-221 sensitizes human colorectal carcinoma cells to radiation by upregulating PTEN. , 2013, World journal of gastroenterology.

[48]  Shadan Ali,et al.  Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. , 2013, American journal of cancer research.

[49]  H. Höfler,et al.  MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion , 2013, British Journal of Cancer.

[50]  Yang Di,et al.  Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis , 2013, Medical Oncology.

[51]  D. Dornan,et al.  miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer , 2013, PloS one.

[52]  Michael A. Freitas,et al.  In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation , 2013, The Journal of experimental medicine.

[53]  Xianming Chen,et al.  HIV Tat Induces Expression of ICAM-1 in HUVECs: Implications for miR-221/-222 in HIV-Associated Cardiomyopathy , 2013, PloS one.

[54]  Ming-Yu Yang,et al.  Altered expression of SIRT gene family in head and neck squamous cell carcinoma , 2013, Tumor Biology.

[55]  M. Cannataro,et al.  In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma , 2013, Oncotarget.

[56]  L. Panasci,et al.  Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond , 2012, Front. Pharmacol..

[57]  K. Aldape,et al.  ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect , 2012, Nature Cell Biology.

[58]  Min Han,et al.  Inner Nuclear Envelope Proteins SUN1 and SUN2 Play a Prominent Role in the DNA Damage Response , 2012, Current Biology.

[59]  C. Croce,et al.  Liver tumorigenicity promoted by microRNA‐221 in a mouse transgenic model , 2012, Hepatology.

[60]  Kaishun Hu,et al.  MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene , 2012, Cell cycle.

[61]  H. Klocker,et al.  Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway. , 2012, Carcinogenesis.

[62]  R. Zhong,et al.  Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma , 2012, Medical Oncology.

[63]  D. Kang,et al.  Identification of Serum MicroRNAs as Novel Non-Invasive Biomarkers for Early Detection of Gastric Cancer , 2012, PloS one.

[64]  C. Croce,et al.  miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ , 2012, Oncogene.

[65]  T. Jiang,et al.  Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status. , 2011, Oncology reports.

[66]  Lei Han,et al.  High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma , 2012, Journal of Translational Medicine.

[67]  Xiulian Du,et al.  Structure of Sad1-UNC84 Homology (SUN) Domain Defines Features of Molecular Bridge in Nuclear Envelope* , 2011, The Journal of Biological Chemistry.

[68]  T. Nguyen,et al.  The LINC complex and human disease. , 2011, Biochemical Society transactions.

[69]  R. Bourgon,et al.  miR-221/222 Targeting of Trichorhinophalangeal 1 (TRPS1) Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer , 2011, Science Signaling.

[70]  Wanjun Yu,et al.  Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. , 2011, Biochemical and biophysical research communications.

[71]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[72]  Y. Inoue,et al.  The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. , 2011, Journal of dermatological science.

[73]  Wei Wang,et al.  MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma , 2011, Acta Pharmacologica Sinica.

[74]  S. Elledge,et al.  The DNA damage response: making it safe to play with knives. , 2010, Molecular cell.

[75]  Heidi N. Fridolfsson,et al.  Interactions between nuclei and the cytoskeleton are mediated by SUN-KASH nuclear-envelope bridges. , 2010, Annual review of cell and developmental biology.

[76]  Tongyu Lin,et al.  Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression , 2010, Journal of gastroenterology and hepatology.

[77]  J. Cheng,et al.  MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma , 2010, Molecular Cancer.

[78]  Z. Miao,et al.  Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics , 2010, Acta Pharmacologica Sinica.

[79]  P. Pu,et al.  MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN , 2010, BMC Cancer.

[80]  G. Gundersen,et al.  Dynamics and molecular interactions of linker of nucleoskeleton and cytoskeleton (LINC) complex proteins , 2009, Journal of Cell Science.

[81]  Denis Wirtz,et al.  A perinuclear actin cap regulates nuclear shape , 2009, Proceedings of the National Academy of Sciences.

[82]  Tian Xu,et al.  SUN1/2 and Syne/Nesprin-1/2 Complexes Connect Centrosome to the Nucleus during Neurogenesis and Neuronal Migration in Mice , 2009, Neuron.

[83]  Gian Luca Grazi,et al.  MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality , 2009, Clinical Cancer Research.

[84]  Hao Jiang,et al.  Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. , 2009, International journal of oncology.

[85]  V. Narry Kim,et al.  Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer , 2009, Nucleic acids research.

[86]  Dazhi Xu,et al.  Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma , 2009, Journal of experimental & clinical cancer research : CR.

[87]  P. A. van den Brandt,et al.  Lamin A/C Is a Risk Biomarker in Colorectal Cancer , 2008, PloS one.

[88]  Denis Wirtz,et al.  Structural requirements for the assembly of LINC complexes and their function in cellular mechanical stiffness. , 2008, Experimental cell research.

[89]  S. K. Zaidi,et al.  MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. , 2008, Cancer research.

[90]  J Wade Harper,et al.  The DNA damage response: ten years after. , 2007, Molecular cell.

[91]  Michael F Clarke,et al.  The biology of cancer stem cells. , 2007, Annual review of cell and developmental biology.

[92]  C. Stewart,et al.  Transmembrane protein Sun2 is involved in tethering mammalian meiotic telomeres to the nuclear envelope , 2007, Proceedings of the National Academy of Sciences.

[93]  Xiulian Du,et al.  Characterization of the structures involved in localization of the SUN proteins to the nuclear envelope and the centrosome. , 2006, DNA and cell biology.

[94]  Katherine L. Wilson,et al.  SUN-domain proteins: 'Velcro' that links the nucleoskeleton to the cytoskeleton , 2006, Nature Reviews Molecular Cell Biology.

[95]  R. Trembath,et al.  SUN1 Interacts with Nuclear Lamin A and Cytoplasmic Nesprins To Provide a Physical Connection between the Nuclear Lamina and the Cytoskeleton , 2006, Molecular and Cellular Biology.

[96]  Qian Liu,et al.  Citation for Published Item: Use Policy Coupling of the Nucleus and Cytoplasm: Role of the Linc Complex , 2022 .

[97]  Daniel A Starr,et al.  KASH 'n Karry: The KASH domain family of cargo‐specific cytoskeletal adaptor proteins , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[98]  A. Noegel,et al.  The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope , 2005, Journal of Cell Science.

[99]  M. Fraga,et al.  Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  D. Hodzic,et al.  Sun2 Is a Novel Mammalian Inner Nuclear Membrane Protein* , 2004, Journal of Biological Chemistry.

[101]  Vera Rogiers,et al.  Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. , 2004, Current medicinal chemistry.

[102]  M. O’Bryan,et al.  Human sperm associated antigen 4 (SPAG4) is a potential cancer marker , 2004, Cell and Tissue Research.

[103]  S. Kyrylenko,et al.  Differential regulation of the Sir2 histone deacetylase gene family by inhibitors of class I and II histone deacetylases , 2003, Cellular and Molecular Life Sciences CMLS.

[104]  Min Han,et al.  ANChors away: an actin based mechanism of nuclear positioning , 2003, Journal of Cell Science.

[105]  J. Broers,et al.  Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma , 2003, The British journal of dermatology.

[106]  Min Han,et al.  Lamin-dependent localization of UNC-84, a protein required for nuclear migration in Caenorhabditis elegans. , 2002, Molecular biology of the cell.

[107]  T. Schöneberg,et al.  Nuclear envelope proteomics: Novel integral membrane proteins of the inner nuclear membrane , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[108]  C. Hutchison,et al.  Expression of individual lamins in basal cell carcinomas of the skin , 2001, British Journal of Cancer.

[109]  V. Yamazaki,et al.  A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage , 2000, Current Biology.

[110]  H. Horvitz,et al.  UNC-84 localizes to the nuclear envelope and is required for nuclear migration and anchoring during C. elegans development. , 1999, Development.

[111]  K. Rajewsky,et al.  Requirement of mammalian DNA polymerase-beta in base-excision repair. , 1996, Nature.

[112]  M. Yanagida,et al.  The product of the spindle formation gene sad1+ associates with the fission yeast spindle pole body and is essential for viability , 1995, The Journal of cell biology.

[113]  S. Wagenaar,et al.  Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. , 1993, The American journal of pathology.

[114]  É. Khandjian,et al.  Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells. , 1990, Leukemia research.